Literature DB >> 23953190

Discovery of novel (1S)-(-)-verbenone derivatives with anti-oxidant and anti-ischemic effects.

Chung Ju1, Sumi Song, Sunyoung Hwang, Chorong Kim, Minkyoung Kim, Jail Gu, Yu-Kyoung Oh, Kyeong Lee, Jinsun Kwon, Kiho Lee, Won-Ki Kim, Yongseok Choi.   

Abstract

A series of novel (1S)-(-)-verbenone derivatives was synthesized bearing a 4-styryl scaffold. The synthesized compounds were tested for their anti-oxidant, anti-excitotoxic, and anti-ischemic activities. These derivatives significantly reduced oxygen-glucose deprivation-induced neuronal injury and N-methyl-D-aspartic acid-evoked excitotoxicity in cortical neurons. Furthermore, compound 3f was identified as a potent anti-ischemic agent in an in vitro ischemic model, potentially due to the inhibition of N-methyl-D-aspartic acid-evoked excitotoxicity and oxidative/nitrosative stress.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-excitotoxic activity; Anti-ischemic activity; Anti-oxidant activity; Cerebral ischemia; Verbenone

Mesh:

Substances:

Year:  2013        PMID: 23953190     DOI: 10.1016/j.bmcl.2013.07.038

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Anticonvulsive activity of (1S)-(-)-verbenone involving RNA expression of BDNF, COX-2, and c-fos.

Authors:  Cynthia Germoglio Farias de Melo; Paula Regina Rodrigues Salgado; Diogo Vilar da Fonsêca; Renan Marinho Braga; Marcelo Ricardo Dutra Caldas Filho; Ingrid Eulália Vieira de Farias; Hilzeth de Luna Freire Pessôa; Eleonidas Moura Lima; Ian Porto Gurgel do Amaral; Damião Pergentino de Sousa; Reinaldo Nóbrega de Almeida
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-06-02       Impact factor: 3.000

2.  A novel CD147 inhibitor, SP-8356, reduces neointimal hyperplasia and arterial stiffness in a rat model of partial carotid artery ligation.

Authors:  Kisoo Pahk; Hyojin Noh; Chanmin Joung; Mi Jang; Hwa Young Song; Kyung Won Kim; Kihoon Han; Jong-Ik Hwang; Sungeun Kim; Won-Ki Kim
Journal:  J Transl Med       Date:  2019-08-20       Impact factor: 5.531

3.  SP-8356, a (1S)-(-)-verbenone derivative, exerts in vitro and in vivo anti-breast cancer effects by inhibiting NF-κB signaling.

Authors:  Sunam Mander; Dong Hwi Kim; Huong Thi Nguyen; Hyo Jeong Yong; Kisoo Pahk; Eun-Yeong Kim; Kiho Lee; Jae Young Seong; Won-Ki Kim; Jong-Ik Hwang
Journal:  Sci Rep       Date:  2019-04-29       Impact factor: 4.379

4.  SP-8356, a Novel Inhibitor of CD147-Cyclophilin A Interactions, Reduces Plaque Progression and Stabilizes Vulnerable Plaques in apoE-Deficient Mice.

Authors:  Kisoo Pahk; Chanmin Joung; Hwa Young Song; Sungeun Kim; Won-Ki Kim
Journal:  Int J Mol Sci       Date:  2019-12-21       Impact factor: 5.923

Review 5.  Anticonvulsant Essential Oils and Their Relationship with Oxidative Stress in Epilepsy.

Authors:  Diogo Vilar da Fonsêca; Carlos da Silva Maia Bezerra Filho; Tamires Cardoso Lima; Reinaldo Nóbrega de Almeida; Damião Pergentino de Sousa
Journal:  Biomolecules       Date:  2019-12-06

6.  Metabolism and Pharmacokinetics of SP-8356, a Novel (1S)-(-)-Verbenone Derivative, in Rats and Dogs and Its Implications in Humans.

Authors:  Yuanyuan Zhou; Mun Hwan Oh; Yeon Joon Kim; Eun-Yeong Kim; Jinhong Kang; Sung Chung; Chung Ju; Won-Ki Kim; Kiho Lee
Journal:  Molecules       Date:  2020-04-13       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.